Lastly, we herein show that Gal-3 expression is significantly increased in the frontal lobe of AD patients in parallel with enhanced Aβ oligomerization, and that the serum level of Gal-3 increases with the severity of memory loss in AD patients. The gene discussed is LGALS3; the disease is Alzheimer disease.